I am a
Home I AM A Search Login

Papers of the Week

2022 Dec 08

Antioxidants (Basel)



Alpha-Lipoic Acid as an Antioxidant Strategy for Managing Neuropathic Pain.


Viana M D M, Santana Sales Lauria P, de Lima A A, Opretzka L C F, Marcelino H R, Villarreal C F
Antioxidants (Basel). 2022 Dec 08; 11(12).
PMID: 36552628.


Neuropathic pain (NP) is the most prevalent and debilitating form of chronic pain, caused by injuries or diseases of the somatosensory system. Since current first-line treatments only provide poor symptomatic relief, the search for new therapeutic strategies for managing NP is an active field of investigation. Multiple mechanisms contribute to the genesis and maintenance of NP, including damage caused by oxidative stress. The naturally occurring antioxidant alpha-lipoic acid (ALA) is a promising therapeutic agent for the management of NP. Several pre-clinical in vitro and in vivo studies as well as clinical trials demonstrate the analgesic potential of ALA in the management of NP. The beneficial biological activities of ALA are reflected in the various patents for the development of ALA-based innovative products. This review demonstrates the therapeutic potential of ALA in the management of NP by discussing its analgesic effects by multiple antioxidant mechanisms as well as the use of patented ALA-based products and how technological approaches have been applied to enhance ALA's pharmacological properties.